Long-Term Extension Study of Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: HEADWAY-DLB Extension
Clinical trial NCT02928445 · TERMINATED
Trial details
- NCT number
- NCT02928445
- Sponsor
- Axovant Sciences Ltd.
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-01
- Primary completion
- 2018-02-01
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.